Background illustration for clinical trials search

Paid Clinical Trials Washington, D.C.

Discover 775 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

for
Advanced Lung Non-Squamous Non-Small Cell Carcinoma,
Location: Washington D.C. DC, Hanover PA, Gettysburg PA, York PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04181060

Phase 3, Recruiting

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

for
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
Location: Washington D.C. DC, Kensington MD, McLean VA, Largo MD,
Sponsor: NRG Oncology

Sex: All

Age: 45 - 70

Code: NCT05080673

Recruiting

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

for
Metastatic Malignant Neoplasm in the Liver,
Location: Washington D.C. DC, Baltimore MD, Richmond VA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05040360

Phase 2, Recruiting

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

for
Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma (RCC),
Location: Washington D.C. DC, Glen Burnie MD, Baltimore MD,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06661720

Phase 3, Recruiting

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Washington D.C. DC, Glen Burnie MD, Baltimore MD,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06058377

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Location: Washington D.C. DC, Bethesda MD, Hyattsville MD,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06129864

Phase 3, Recruiting

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

for
Viral Lung Infection and Acute Respiratory Failure
Location: Washington D.C. DC, Annapolis MD, Charlottesville VA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT05624450

Phase 3, Recruiting

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

for
Chronic Kidney Disease and Hypertension
Location: Washington D.C. DC, Arlington VA, Bethesda MD,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06742723

Phase 3, Recruiting

Research Accelerated by You Lupus Registry

for
Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN),
Location: Washington D.C. DC
Sponsor: Lupus Foundation of America

Sex: All

Age: 0+

Code: NCT06927219

Recruiting

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

for
Graves' Disease
Location: Washington D.C. DC, Baltimore MD, Newark DE,
Sponsor: Immunovant Sciences GmbH

Sex: All

Age: 18 - 70+

Code: NCT06727604

Phase 2, Recruiting

A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures

for
Stereotypical Prolonged Seizures
Location: Washington D.C. DC, Winchester VA, Philadelphia PA,
Sponsor: UCB Biopharma SRL

Sex: All

Age: 12+

Code: NCT05077904

Phase 3, Recruiting

A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus

for
Lichen Sclerosus
Location: Washington D.C. DC, Philadelphia PA, New York NY,
Sponsor: LEO Pharma

Sex: All

Age: 18+

Code: NCT07335588

Phase 3, Recruiting

Apple Health Study

for
Mental Health, Sleep, Exercise, Hormones, Metabolic Health,
Location: Washington D.C. DC, Boston MA
Sponsor: Apple Inc.

Sex: All

Age: 18+

Code: NCT06958523

Recruiting

Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding

for
Fabry Disease, Pregnancy, Pregnancy Complications
Location: Washington D.C. DC
Sponsor: Chiesi Farmaceutici S.p.A.

Sex: Female

Age: 0+

Code: NCT06941025

Recruiting

Stress, Sleep and Cardiovascular Risk

for
Posttraumatic Stress Disorder, Insomnia
Location: Washington DC
Sponsor: Howard University

Sex: All

Age: 18 - 35

Code: NCT03487991

Recruiting

BRAVE Program to Improve Safety and Reduce Violence Risk in Early Psychosis

for
Violence Risk, Early Psychosis
Location: Washington D.C. DC
Sponsor: Howard University

Sex: All

Age: 16 - 30

Code: NCT07417904

Recruiting

Changes in Biochemical Markers of Bone Turnover (Serum CTX and PlNP) After Initiation of a "Drug Holiday" From Bisphosphonates

for
Osteoporosis
Location: Washington DC
Sponsor: National Bone Health Alliance

Sex: All

Age: 50+

Code: NCT02575157

Recruiting

El Camino HIV Prevention and Care Study

for
HIV Infections
Location: Washington D.C. DC
Sponsor: American University

Sex: Male

Age: 18+

Code: NCT07834853

Recruiting

Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors

for
Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors,
Location: Washington D.C. DC, Durham NC, Cincinnati OH,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 1 - 70+

Code: NCT05868629

Recruiting

IGNITE: Study of Tirabrutinib vs Rituximab and Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)

for
Relapsed/Refractory Primary Central Nervous System Lymphoma
Location: Washington D.C. DC, Baltimore MD, Hershey PA,
Sponsor: Ono Pharmaceutical Co., Ltd.

Sex: All

Age: 18+

Code: NCT07104032

Phase 3, Recruiting